RU-58841 RU58841 CAS: 154992-24-2

CAS NO: 154992-24-2
RU-58841 RU58841
Chemical Name: RU 58841
Molecular Formula: C17H18F3N3O3
Formula Weight: 369.34
CAS No.: 154992-24-2
Description Review
Description

RU-58841 RU58841 CAS: 154992-24-2 is a nonsteroidal antiandrogen (NSAA) that was developed as a topical treatment for male pattern baldness. It works by blocking the action of androgens, which are hormones responsible for hair loss in men.

Chemical Name:

RU-58841 is also known as 4-{[(4-methyl-1H-imidazol-5-yl)sulfonyl]phenyl}-(2H)-phthalazinone.

Molecular Formula:

The molecular formula of RU-58841 is C17H18N4O2S.

Formula Weight:

The formula weight of RU-58841 is 348.42 g/mol.

CAS No:

The CAS number of RU-58841 is 154992-24-2.

Top Ten Keywords from Google and Synonyms:

  1. Hair Loss Treatment
  2. Androgen Blocker
  3. Male Pattern Baldness Treatment
  4. Topical Solution
  5. Anti-Aging Supplement
  6. Hair Regrowth Agent
  7. Hair Growth Stimulant
  8. Dermatological Agent
  9. Hair Restoration Treatment
  10. Nonsteroidal Antiandrogen

Health Benefits of RU-58841:

RU-58841 is primarily used to treat male pattern baldness. However, it has also shown potential health benefits in other areas such as anti-aging and hormonal balance. Some of the potential benefits of RU-58841 include:

  1. Hair Regrowth: RU-58841 may promote hair regrowth and prevent further hair loss in individuals with male pattern baldness.

  2. Anti-Aging: RU-58841 may have anti-aging effects by reducing the activity of androgens that contribute to age-related changes in skin and hair.

Potential Effects:

RU-58841 can produce a range of effects depending on the dosage and individual response. Some of the potential effects of RU-58841 include:

  1. Hair Regrowth: RU-58841 may promote hair regrowth and prevent further hair loss in individuals with male pattern baldness.

  2. Reduced Androgen Activity: RU-58841 may reduce the activity of androgens, which can contribute to hair loss and other age-related changes.

Product Mechanism:

RU-58841 works by blocking the action of androgens, which are hormones responsible for hair loss in men. By inhibiting androgen receptors, RU-58841 can prevent the damaging effects of androgens on hair follicles.

Safety:

RU-58841 can be safe when used appropriately and under medical supervision. However, it can cause adverse effects if misused or abused. Some of the potential side effects of RU-58841 include:

  1. Skin Irritation: RU-58841 may cause skin irritation or allergic reactions in some individuals.

  2. Hormonal Imbalance: RU-58841 may affect hormone levels and potentially lead to hormonal imbalances in some individuals.

Dosing Information:

The appropriate dose of RU-58841 depends on several factors such as age, weight, and health status. It is essential to follow dosing instructions carefully and not exceed the recommended dose.

Conclusion:

RU-58841 is a nonsteroidal antiandrogen (NSAA) that was developed as a topical treatment for male pattern baldness. While RU-58841 may provide some health benefits, it should only be used under medical supervision and with caution due to its potential side effects. Additionally, more research is needed to fully understand its safety and efficacy in humans

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code